ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 994

IL-7 Modulates B Cell Immunoglobulin Isotype Production and Increases B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) in Synovial Fibroblasts from Osteoarthritis (OA) and Rheumatoid Arthritis (RA) Patients

Georg Pongratz1, Stephan Kuhn2, Madlen Melzer2, Torsten Lowin2 and Rainer Straub3, 1Internal Medicine I, University Hospital Regensburg, Regensburg, Germany, 2University Hospital Regensburg, Regensburg, Germany, 3Internal Medicine, University Hospital Regensburg, Regensburg, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Arthritis, B cells, Fibroblasts, immunoglobulin (IG) and interleukins (IL)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Biology and Targets in Autoimmune Disease: Rheumatoid Arthritis and Related Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose

Interleukin(IL)-7 is increased in synovial fluid from rheumatoid arthritis (RA) patients as compared to osteoarthritis (OA) patients and has been attributed a proinflammatory role, especially due to its well established influence on T cells. However, B cells and synovial fibroblasts (SFs) also possess functional IL-7 receptors and stimulation of IL-7 receptors on B cells increases disease severity in collagen-induced arthritis. However, the mechanisms involved in this proinflammatory effect are not known. We therefore wanted to further characterize the effect of IL-7 on B cell antibody production and on the production of B cell activating factor of the tumor necrosis factor family (BAFF) and IL-6 in synovial fibroblasts (SFs).

Methods

Naive splenic mouse B cells were cultured in the presence of different activating stimuli (LPS, anti-IgM, anti-CD40, anti-CD40 +  IL-4, antiCD40 + IFN-γ) in the absence or presence of IL-7 added at different timepoints (with the initial stimulus or three days after start of culture) and different concentrations (0.1, 1.0, 10 ng/ml). Levels of antibody isotypes (IgA, IgM, IgG1, IgG2a, IgG2b, IgG3, IgE) and light chains (lambda, kappa) were determined in supernatant by ELISA after 5 days. SFs were isolated from OA (n=15) and RA (n=7) knee joints and cultured in the presence or absence of IFN-γ at different concentrations (0.1, 0.5, 1.0, 5.0, 10, 50 ng/ml)  to induce BAFF and IL-6 in the absence or presence of different concentrations of IL-7 (0.01, 0.1, 1.0, 10 ng/ml). BAFF and IL-6 were determined in culture supernatants by ELISA.

Results

IL-7 shows a differential effect on B cell antibody production, depending on the co-stimulus used and the isotype analysed. Most prominent effects were observed when IL-7 was present from the beginning of B cell culture. IL-7 increased IgG2a (p=0.038), IgG3 (p<0.001), and lambda light chains (p=0.024) and decreased kappa light chains (p<0.001) in the presence of concomitant stimulation with IL-4 and anti-CD40. IL-7 further increased LPS-induced IgG3 (p<0.001) and IgE (p<0.001). IL-7 alone was able to induce IgE in B cells to some extent without any additional stimulus (p<0.001). IFN-induced BAFF was increased by IL-7 in a concentration dependent manner in RA (p<0.001) but not OA SFs (p=0.078). However, under hypoxic conditions (O2 2%) both, RA (p<0.001) and OA (p=0.008) SFs increased IFN-induced BAFF production in the presence of IL-7 in a concentration dependent manner. In contrast, IFN-induced IL-6 was not altered in SFs in the presence of IL-7.

Conclusion

Effects of IL-7 on the B cell compartment in arthritis can be direct by modulation of isotype production or indirect by increasing BAFF production in SFs. Therefore, IL-7 not only plays a role in modulating T cells but also modulates B cell function in arhtritis and therefore might be a valuable drug target.


Disclosure:

G. Pongratz,
None;

S. Kuhn,
None;

M. Melzer,
None;

T. Lowin,
None;

R. Straub,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-7-modulates-b-cell-immunoglobulin-isotype-production-and-increases-b-cell-activating-factor-of-the-tumor-necrosis-factor-family-baff-in-synovial-fibroblasts-from-osteoarthritis-oa-and-rheumatoi/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology